Meloxicam (Viatris)

美洛昔康 (Viatris)

Report date: 2025/05/21 11:12:33

Base Information

Drug NameMeloxicam (Viatris)
Drug Alias NameMR-107A-02MR-107-A-02
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclooxygenase-2 inhibitorsCyclooxygenase-1 inhibitors
TargetsCyclooxygenase-2Cyclooxygenase-1
Therapy Area/IndicationsAcute PainPainPain, Postoperative
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesPrayog Labs LLC
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsAcute PainPainPain, Postoperative
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A